rs148813816

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152783.5(D2HGDH):​c.292+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00435 in 1,603,698 control chromosomes in the GnomAD database, including 256 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 146 hom., cov: 35)
Exomes 𝑓: 0.0024 ( 110 hom. )

Consequence

D2HGDH
NM_152783.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.08

Publications

0 publications found
Variant links:
Genes affected
D2HGDH (HGNC:28358): (D-2-hydroxyglutarate dehydrogenase) This gene encodes D-2hydroxyglutarate dehydrogenase, a mitochondrial enzyme belonging to the FAD-binding oxidoreductase/transferase type 4 family. This enzyme, which is most active in liver and kidney but also active in heart and brain, converts D-2-hydroxyglutarate to 2-ketoglutarate. Mutations in this gene are present in D-2-hydroxyglutaric aciduria, a rare recessive neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. [provided by RefSeq, Jul 2008]
D2HGDH Gene-Disease associations (from GenCC):
  • D-2-hydroxyglutaric aciduria 1
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • D-2-hydroxyglutaric aciduria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 2-241735525-G-A is Benign according to our data. Variant chr2-241735525-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0769 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
D2HGDHNM_152783.5 linkc.292+9G>A intron_variant Intron 2 of 9 ENST00000321264.9 NP_689996.4 Q8N465-1B4E3K7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
D2HGDHENST00000321264.9 linkc.292+9G>A intron_variant Intron 2 of 9 1 NM_152783.5 ENSP00000315351.4 Q8N465-1

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3484
AN:
152236
Hom.:
143
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0790
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00929
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.00549
AC:
1265
AN:
230502
AF XY:
0.00393
show subpopulations
Gnomad AFR exome
AF:
0.0756
Gnomad AMR exome
AF:
0.00372
Gnomad ASJ exome
AF:
0.000819
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000201
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00240
AC:
3477
AN:
1451344
Hom.:
110
Cov.:
39
AF XY:
0.00201
AC XY:
1449
AN XY:
722572
show subpopulations
African (AFR)
AF:
0.0828
AC:
2770
AN:
33446
American (AMR)
AF:
0.00441
AC:
197
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.000996
AC:
26
AN:
26098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39670
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86192
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43762
Middle Eastern (MID)
AF:
0.00356
AC:
20
AN:
5624
European-Non Finnish (NFE)
AF:
0.000118
AC:
131
AN:
1111638
Other (OTH)
AF:
0.00530
AC:
319
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
177
354
531
708
885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0230
AC:
3500
AN:
152354
Hom.:
146
Cov.:
35
AF XY:
0.0214
AC XY:
1594
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.0791
AC:
3290
AN:
41584
American (AMR)
AF:
0.00927
AC:
142
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68030
Other (OTH)
AF:
0.0194
AC:
41
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
173
346
518
691
864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00819
Hom.:
25
Bravo
AF:
0.0258
Asia WGS
AF:
0.00606
AC:
22
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

D-2-hydroxyglutaric aciduria 1 Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 16, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 31, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
11
DANN
Benign
0.95
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148813816; hg19: chr2-242674940; API